Neuronetics (STIM) PT Lowered to $15 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst William Plovanic lowered the price target on Neuronetics (NASDAQ: STIM) to $15.00 (from $21.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
